ASX 200 stock IperionX Ltd (ASX: IPX) shares are trading 3% higher today after the company reported it has secured an additional US$25 million in US government funding to boost its titanium production, taking total obligations under the existing award to US$42.5 million.
What did IperionX report?
- US Department of War provided an extra US$25 million under IperionX's US$47.1 million award
- Total government funding now stands at US$42.5 million, with US$4.6 million to be provided later
- Funding supports scaling up production to 1,400 metric tons per year at the Virginia Titanium Manufacturing Campus
- Previous funding tranches included US$12.5 million and US$5 million
What else do investors need to know?
IperionX says this latest round of funding will be used to ramp up advanced manufacturing capacity at its Virginia facility. The investment is part of the US government's effort to secure a domestic source of titanium, aiming to bolster defence supply chains and reduce reliance on imports.
Earlier funding supported equipment purchases and advanced the Titan Critical Minerals Project in Tennessee. The company notes it expects the remaining US$4.6 million from the US Department of War award to be received during the contract term.
What's next for IperionX?
IperionX plans to use the latest funding to increase titanium output and further its goal of establishing a resilient, integrated supply chain in the United States. The company's strategy includes ongoing development of both its Virginia manufacturing site and the Titan project in Tennessee.
Looking ahead, IperionX remains focused on delivering cost-effective, sustainable titanium metals and supporting growth in key sectors such as defence, aerospace, and advanced manufacturing.
IperionX share price snapshot
IperionX shares have soared more than 130% in a year, far outpacing the S&P/ASX 200 Index (ASX: XJO) which is up around 8% in that timeframe.
